How can erythropoeitin-stimulating agent use be reduced in chronic dialysis patients?: The use of iron supplementation to reduce ESA dosing in hemodialysis.
2013
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
30
References
0
Citations
NaN
KQI